SomnoMed
-
Ticker
SOM
-
Industry
--None-- More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in Crows Nest, Australia
SomnoMed is the global leader in Open Airway Therapy (OAT) devices for the treatment of mild-to-moderate obstructive sleep apnea, and has innovated OSA treatment options since 2004. Each custom-made device is designed with patient comfort and therapy effectiveness as the priority, and we strive with the dental and healthcare communities to support 100% therapy compliance in OSA treatment.
SomnoMed
Most Recent Annual Report
MOST RECENT
2021 Annual Report
Older/Archived Annual Reports